Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>The designer, manufacturer and supplier of advanced testing, simulation and measurement products and services to the global transport market provided a trading update in respect of the year ended 31 August.</li>
<li>Further to the update issued on 28 July, the Board confirmed that the trading in the remainder of the final quarter was as anticipated and consequently performance for FY2026 is expected to be in line with the guidance provided at the time and current market expectations.</li>
<li>Revenue for the year from continuing operations is expected to be £91.6m and adjusted operating margin is in line with the Group's medium-term target of 20%. </li>
</ul>


The designer, manufacturer and supplier of advanced testing, simulation and measurement products and services to the global transport market provided a trading update in respect of the year ended 31 August.
Further to the update issued on 28 July, the Board confirmed that the trading in the remainder of the final quarter was as anticipated and consequently performance for FY2026 is expected to be in line with the guidance provided at the time and current market expectations.
Revenue for the year from continuing operations is expected to be £91.6m and adjusted operating margin is in line with the Group's medium-term target of 20%. 


Hybridan Small Cap Feast: 17 September 2026

<ul>
<li>Abingdon Health 8.25p £20.71m (ABDX.L) The developer, manufacturer and regulatory services provider for rapid diagnostic tests and medtech reports H1 to December 2025.</li>
<li>Reported revenue is 37% higher at £4.2m, with an EBITDA loss of £1.7m compared to an EBITDA loss of £1.9m due to continued investment in the overhead base to support future growth and contract execution.</li>
<li>The net cash is £3.7m against £1.9m last year and after a fund raising in October 2025 of £3.2m to accelerate US expansion and support execution of major contracts. </li>
</ul>


Abingdon Health 8.25p £20.71m (ABDX.L) The developer, manufacturer and regulatory services provider for rapid diagnostic tests and medtech reports H1 to December 2025.
Reported revenue is 37% higher at £4.2m, with an EBITDA loss of £1.7m compared to an EBITDA loss of £1.9m due to continued investment in the overhead base to support future growth and contract execution.
The net cash is £3.7m against £1.9m last year and after a fund raising in October 2025 of £3.2m to accelerate US expansion and support execution of major contracts. 


<ul>
<li>The Africa-focused lithium exploration and development Company targeting the delivery of Ghana’s first lithium mine updates on the Mining Lease Ewoyaa Lithium Project.</li>
<li>The Mining Lease has been submitted to the Parliament of Ghana to be considered, as per due process for ratification.</li>
<li>The mining lease provides exclusive rights to carry out mining and commercial production activities at Ewoyaa for an initial 15-year period.</li>
</ul>


The Africa-focused lithium exploration and development Company targeting the delivery of Ghana’s first lithium mine updates on the Mining Lease Ewoyaa Lithium Project.
The Mining Lease has been submitted to the Parliament of Ghana to be considered, as per due process for ratification.
The mining lease provides exclusive rights to carry out mining and commercial production activities at Ewoyaa for an initial 15-year period.


Hybridan Small Cap Feast: 12 November 2025

<ul>
<li>12th May: Cobalt Holdings, a Company created primarily to purchase and hold physical cobalt, offering public equity investors pure-play direct exposure to the price of cobalt, confirmed its intention to raise approximately US$230m through its Global Offer and the Admission on to the Main Market in June 2025.</li>
<li>Glencore International AG and certain entities and affiliates managed by Anchorage Structured Commodities Advisor, have agreed to participate as cornerstone investors, agreeing to invest, in aggregate, an amount representing approximately 20.5% of the Shares to be offered pursuant to the Global Offer.</li>
<li>9th May: iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, announces that it has confirmed its intention to IPO onto the Main Market. T</li>
</ul>


12th May: Cobalt Holdings, a Company created primarily to purchase and hold physical cobalt, offering public equity investors pure-play direct exposure to the price of cobalt, confirmed its intention to raise approximately US$230m through its Global Offer and the Admission on to the Main Market in June 2025.
Glencore International AG and certain entities and affiliates managed by Anchorage Structured Commodities Advisor, have agreed to participate as cornerstone investors, agreeing to invest, in aggregate, an amount representing approximately 20.5% of the Shares to be offered pursuant to the Global Offer.
9th May: iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, announces that it has confirmed its intention to IPO onto the Main Market. T


Australia

Atlantic Lithium is an exploration and development company focused on advancing lithium mining projects in West Africa. Its core asset is the Ewoyaa Lithium Project in Ghana, which is on track to become Ghana's first lithium-producing mine. The company's activities center on extracting lithium spodumene to supply raw materials for batteries used in electric vehicles and energy storage. Atlantic Lithium was founded in 2007 and is headquartered in Sydney, Australia.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Atlantic Lithium (ALL LN)

Hybridan Small Cap Feast: 17 September 2026

The designer, manufacturer and supplier of advanced testing, simulation and measurement products and services to the global transport market...

Hybridan

Hybridan Small Cap Feast: 17 March 2026

Abingdon Health 8.25p £20.71m (ABDX.L) The developer, manufacturer and regulatory services provider for rapid diagnostic tests and medtech reports...

Hybridan

Hybridan Small Cap Feast: 12 November 2025

The Africa-focused lithium exploration and development Company targeting the delivery of Ghana’s first lithium mine updates on the Mining Lease...

Hybridan

Hybridan Small Cap Feast: 22/05/2025

Cobalt Holdings, a Company created primarily to purchase and hold physical cobalt, offering public equity investors pure-play direct exposure to...

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)